MOLN
Molecular Partners AG ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$144.78M
P/E Ratio
—
EPS
$-2.06
Beta
0.74
52W High
$5.36
52W Low
$3.36
50-Day MA
$4.55
200-Day MA
$4.06
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.70
PEG Ratio
—
About Molecular Partners AG ADR
Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-39.14M |
| EBITDA | $-54.54M |
| Operating Margin | 0.00% |
| Return on Equity | -55.50% |
| Return on Assets | -26.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.69 |
| Price-to-Book | 1.43 |
| Price-to-Sales (TTM) | 158.42 |
| EV/Revenue | 0.954 |
| EV/EBITDA | 1.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $37.41M |
| Float | $17.50M |
| % Insiders | 0.00% |
| % Institutions | 9.60% |
Analyst Ratings
Consensus ($11.16 target)
4
Buy1
HoldData last updated: 4/8/2026